Director, HTA, Value & Evidence, Lung Cancer

ROLE SUMMARY The Director, HTA, Value & Evidence (HV&E), US, Lung Cancer will support the strategic goals of the Oncology Division by driving optimal patient access & appropriate use of medicines within the lung cancer & precision medicine portfolio. This role directly impacts the ability to achieve business objectives on a US basis by providing strategic guidance and robust evidence development relevant to achieve appropriate use by providers and optimal patient access by demonstrating the val…